CPhI China

Activities: Ingredients

Trending Articles

  1. You need to be a subscriber to read this article.
    Click here to find out more.
    NICE approval is not enough: why the UK’s next medicines challenge is operational delivery A medicine is not truly accessible until it can be manufactured, procured, stocked, prescribed, dispensed and delivered reliably. That distinction is becoming increasingly...
  2. Strengthening US pharmaceutical supply: SCHOTT Pharma inaugurates expanded vial production in Lebanon, PA SCHOTT Pharma has inaugurated new production lines for both standard and sterile ready-to-use (RTU) glass vials designed to store a wide range of drugs — from biologics and...
  3. Stipple Bio enters into multi-target license agreement with Lonza to advance precision oncology ADC therapies Stipple Bio’s Pointillist Platform identifies tumour-specific cell surface epitopes that, when combined with Lonza’s clinically validated ADC platform, may enable...
  4. Ardena appoints Ariane de Ganck as Chief Scientific Officer Ardena, a specialist pharmaceutical CDMO and bioanalytical CRO enabling precision medicines and complex therapies, today announced the appointment of Ariane de Ganck, PhD, as...
  5. Compact, economical and sustainable cooling solutions for laboratories Huber Unichillers offer space-saving and environmentally friendly temperature control for research and industrial applications

Upcoming event

BIO International Convention

22–25 June 2026 | Convention | Boston, US See all

Related Content

Research & Development

Review: CPhI and P-MEC China 2019

International visitors to the three-day event in Shanghai skyrockets more than 74% mirroring the interest for manufacturing locally
Media

The great hall of China

The outlook looks positive for the development of the Chinese pharmaceutical market following CPhI China
Manufacturing

Powder testing solutions at CPhI China

Freeman Technology will be exhibiting on Booth N1A17 at CPhI China, at Shanghai New InternationalExpoCenter Shanghai, China, 20–22 June 2017
Manufacturing

CPhI China to launch China Pharma Week

Expanded week of dedicated sessions and trends on the world’s second largest pharma market
Manufacturing

Chinese companies increase services in finished dosage, exports and bio services at CPhI China 2016

Some 4,500 formulations across 60 dosage forms, with 700 APIs and 200 finished products for Western markets will be present at CPhI China
Media

China: domestic growth to outpace exports, forecasts CPhI China 2015 report

Emerging cities, biopharmaceuticals and APIs to drive future expansion

CPhI and P-MEC China closes as the Chinese domestic market continues to expand

International companies are looking to gain a foothold in this lucrative and expanding pharma economy
Subscribe now